A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Trial design: 4-arm parallel, placebo-controlled, double-blind randomized clinical trial with an allocation ratio of 1:1:1:1. Methods: Microbial count of Streptococcus spp., Plaque Index, Gingival ...

The company stated that the FOCUS study was initially designed and conducted as a randomized controlled trial but was amended to a single-arm design. As a result, comparative efficacy analyses were ...

The FOCUS study was initially designed and conducted as a randomized controlled trial but was amended to a single-arm design. As a result, comparative efficacy analyses were designated as exploratory.

The FOCUS study was initially designed and conducted as a randomized controlled trial but was amended to a single-arm design. As a result, comparative efficacy analyses were designated as exploratory.

Design: Longitudinal, randomized, comparative effectiveness trial with collaborative goal setting. Setting: Research laboratory at a rehabilitation hospital and in participants' homes and communities.

A Randomized Comparative Trial of 3 Commonly Used Designs,” appears in the December 9, 2022, edition of The Journal of Bone and Joint Surgery. “If you decide to resurface, surgeons need some clarity ...

Background: Berubicin (also known as WP744) is a patented doxorubicin (Dox) analog with evidence that it crosses the BBB and has significant central nervous system (CNS) uptake. Induction of apoptosis ...